[Ortho] Два протеза или .........?

[В. Машталов]

Андрей спасибо! Обзоры есть, н0 не все их могут искать..
С благодарностью  В Машталов


2013/6/11 Середа Андрей <drsereda на gmail.com>

>
> Но как выжавают короткие ножки.? Вопрос на колокольню разновеликих
>>  эндопротезистов.
>>
> На то есть обзор.
>
> Hip Int. <http://www.ncbi.nlm.nih.gov/pubmed/22878970#> 2012
> Jul-Aug;22(4):344-54. doi: 10.5301/HIP.2012.9472.
> Survival of short hip stems with a "modern", trochanter-sparing design - a
> systematic literature review.
> Rometsch E<http://www.ncbi.nlm.nih.gov/pubmed?term=Rometsch%20E%5BAuthor%5D&cauthor=true&cauthor_uid=22878970>
> , Bos PK<http://www.ncbi.nlm.nih.gov/pubmed?term=Bos%20PK%5BAuthor%5D&cauthor=true&cauthor_uid=22878970>
> , Koes BW<http://www.ncbi.nlm.nih.gov/pubmed?term=Koes%20BW%5BAuthor%5D&cauthor=true&cauthor_uid=22878970>
> .
>  Source
>
> Department of Orthopaedics, Erasmus Medical Centre, Rotterdam, The
> Netherlands. clinicalscience.er на gmail.com
> Abstract
>
> Modern total hip arthroplasty delivers excellent and reproducible results.
> New implant developments include a wide range of implants with a bone and
> tissue sparing design, including short femoral stems. This review was
> performed to provide an overview on the currently published survival
> results of short stems to allow comparison with the results of traditional
> hip stems. A literature search was performed to identify publications on
> short stems with a "modern" trochanter sparing design including implant
> survival information. Information was collected on the study population,
> follow-up time, implants used, implant survival and functional scores. The
> revision rate per 100 observed component years was calculated and compared
> to data presented in national arthroplasty registries. The methodological
> quality was assessed by employing a score specific to survival assessment
> of hip stems. In the course of 16 individual searches in EMBASE and
> Medline, 460 potentially eligible articles were identified. After thorough
> screening, 14 articles were deemed applicable. The variability in quality
> of the publications was high. No association between survival outcome and
> publication quality was apparent. The total revision rate over all studies
> was found to be 0.38 per 100 component years with endpoint "stem revision
> for any reason". The survival rate of these stems is encouraging and
> appears to be comparable with that of more traditional uncemented stems.
> However, only few mid-term and long-term studies are available. Reports
> with longer follow-up are needed to draw further conclusions.
>
>
> --
> C уважением, Середа Андрей Петрович.
> Sereda Andrey, MD, PhD, orthopaedic surgeon,
> I.M. Sechenov First Moscow State Medical University, Orthopaedic
> department, Deputy Director for Science.
> 6, Bolshaya Pirogovskaya street
> 119991, Moscow, Russia
> *P** **Пожалуйста, не распечатывайте электронные письма и документы без
> реальной необходимости - берегите природу.*
>
> *P** **Please consider the environment before printing this e-mail** **or
> attached document**.** **Moreover what you have print is not you have
> thought about. *
>
> _______________________________________________
> Ortho mailing list
> Ortho на weborto.net
> http://weborto.net:8080/mailman/listinfo/ortho
>
>
----------- следущая часть -----------
Вложение в формате HTML было извлечено&hellip;
URL: http://weborto.net:8080/pipermail/ortho/attachments/20130612/79322829/attachment.htm